KEGG   DRUG: Onartuzumab
Entry
D09941                      Drug                                   
Name
Onartuzumab (USAN/INN);
Onartuzumab (genetical recombination) (JAN)
Formula
C4422H6820N1168O1363S31
Exact mass
99085.1600
Mol weight
99146.54
Sequence
(A chain)
EVQLVESGGG LVQPGGSLRL SCAASGYTFT SYWLHWVRQA PGKGLEWVGM IDPSNSDTRF
NPNFKDRFTI SADTSKNTAY LQMNSLRAED TAVYYCATYR SYVTPLDYWG QGTLVTVSSA
STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG
LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKKVEPK SCDKTHTCPP CPAPELLGGP
SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS
TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSREEM
TKNQVSLSCA VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLVS KLTVDKSRWQ
QGNVFSCSVM HEALHNHYTQ KSLSLSPGK
(B chain)
DKTHTCPPCP APELLGGPSV FLFPPKPKDT LMISRTPEVT CVVVDVSHED PEVKFNWYVD
GVEVHNAKTK PREEQYNSTY RVVSVLTVLH QDWLNGKEYK CKVSNKALPA PIEKTISKAK
GQPREPQVYT LPPSREEMTK NQVSLWCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS
DGSFFLYSKL TVDKSRWQQG NVFSCSVMHE ALHNHYTQKS LSLSPGK
(C chain)
DIQMTQSPSS LSASVGDRVT ITCKSSQSLL YTSSQKNYLA WYQQKPGKAP KLLIYWASTR
ESGVPSRFSG SGSGTDFTLT ISSLQPEDFA TYYCQQYYAY PWTFGQGTKV EIKRTVAAPS
VFIFPPSDEQ LKSGTASVVC LLNNFYPREA KVQWKVDNAL QSGNSQESVT EQDSKDSTYS
LSSTLTLSKA DYEKHKVYAC EVTHQGLSSP VTKSFNRGEC
(Disulfide bridge: A22-A96, A146-A202, A222-C220, A228-B6, A231-B9, A263-A323, A369-A427, B41-B101, B147-B205, C23-C94, C140-C200)
  Type
Peptide
Efficacy
Antineoplastic, Anti-MET antibody
  Type
Monoclonal antibody
Target
MET [HSA:4233] [KO:K05099]
  Pathway
hsa04510  Focal adhesion
hsa04520  Adherens junction
hsa05200  Pathways in cancer
Brite
Target-based classification of drugs [BR:br08310]
 Protein kinases
  Receptor tyrosine kinases (RTK)
   MET family
    MET
     D09941  Onartuzumab (USAN/INN)
Other DBs
CAS: 1133766-06-9
PubChem: 135626673
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system